SCHEMBL5232867

SCHEMBL5232867

Cc1cc(C#Cc2ccc(-c3ccc(Cl)cc3)cn2)ccc1OCC[C](COc1ccc(C#Cc2ccc(-c3ccc(Cl)cc3)cn2)cc1C)C1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 17/20 0.62
CHRM1 P11229 4/20 0.62
HTR2A P28223 3/20 0.45
CYP2D6 P10635 1/20 0.44
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154432 0.90 MCHR1 (0.59) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL5155133 0.86 MCHR1 (0.59) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL2319440 0.82 MCHR1 (0.68) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL4493271 0.81 MCHR1 (0.63) MCHR1CHRM1HTR2ACYP2D6LMNA
SCHEMBL4491965 0.81 MCHR1 (0.63) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL4489001 0.81 MCHR1 (0.63) MCHR1CHRM1HTR2ACYP2D6LMNA
SCHEMBL5199712 0.81 MCHR1 (0.64) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL4471247 0.80 MCHR1 (0.62) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL5230359 0.80 MCHR1 (0.63) MCHR1CHRM1HTR2ACYP2D6CYP1A2
SCHEMBL4493267 0.80 MCHR1 (0.61) MCHR1CHRM1HTR2ACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1737823-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2007-01-03 EP disclosed
WO-2005103002-A2 NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-03 WO disclosed